WallStreetZenWallStreetZen

NASDAQ: ASBP
Aspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Aspire Biopharma Holdings Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-0510,500$0.39
$4.10kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy
Donald G. FellDirector2025-06-049,500$0.39
$3.71kBuy

1 of 1

ASBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ASBP insiders and whales buy or sell their stock.

ASBP Shareholders

What type of owners hold Aspire Biopharma Holdings Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Surendra K. Ajjarapu8.72%4,317,500$1.42MInsider
Powerup Sponsor LLC5.79%2,870,000$947.10kInsider
Toronto Dominion Bank1.04%516,845$170.56kInstitution
Crewe Advisors LLC0.63%313,427$103.43kInstitution
Harraden Circle Investments LLC0.30%150,000$49.50kInstitution
Optivise Advisory Services LLC0.21%106,446$35.13kInstitution
Procyon Advisors LLC0.20%98,500$32.51kInstitution
Periscope Capital Inc0.15%75,000$24.75kInstitution
Platform Technology Partners0.08%37,611$12.41kInstitution
Ubs Group Ag0.06%29,945$9.88kInstitution

1 of 2

ASBP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASBP2.90%14.55%Net BuyingNet Buying
SONN3.42%96.58%
CLGN11.28%0.00%
CTXR4.90%95.10%
CARM13.34%73.98%
View Top Biotech Stocks

Aspire Biopharma Holdings Stock Ownership FAQ

Who owns Aspire Biopharma Holdings?

Aspire Biopharma Holdings (NASDAQ: ASBP) is owned by 2.90% institutional shareholders, 14.55% Aspire Biopharma Holdings insiders, and 82.55% retail investors. Surendra K. Ajjarapu is the largest individual Aspire Biopharma Holdings shareholder, owning 4.32M shares representing 8.72% of the company. Surendra K. Ajjarapu's Aspire Biopharma Holdings shares are currently valued at $1.42M.

If you're new to stock investing, here's how to buy Aspire Biopharma Holdings stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.